How much funding has Vium raised?

Vium has raised $24.0M in total funding, most recently a Series B round.

Who are Vium's investors?

Vium's investors include Lux Capital, DCVC (Data Collab), Dolby Family Ventures, Founders Fund, Future Shape.

Where is Vium headquartered?

Vium is headquartered in San Francisco, California, United States.

Vium

Q: What industry is Vium in?

Vium operates in Artificial Intelligence, Computer Vision, Healthcare, Machine Learning.

Acquired

The digital vivarium for preclinical research

San Francisco, United States · Founded 2013 · $24.0M raised

Artificial Intelligence

Computer Vision

Healthcare

Machine Learning

Headquarters: San Francisco, California
Employees: 11–50
Founded: 2013
Business Model: B2B

Website: vium.com
Total Funding: $24.0M
Last Round: $24.0M Series BJun 2018
Rounds: 2

About

Vium is a biotechnology company that built the first fully digital end-to-end Digital Vivarium platform, using computer vision, machine learning, and sensor technologies to non-invasively transform preclinical in vivo drug research. Founded in 2013 as Mousera by Timothy Robertson and Joe Betts-Lacroix, Vium developed digital biomarkers to accelerate drug discovery and improve animal welfare in research settings. The company was acquired by Recursion Pharmaceuticals in July 2020.

Summary

Vium is an Artificial Intelligence company based in San Francisco, United States, founded in 2013. It has raised $24.0M in total across 2 rounds, most recently a $24.0M Series B round in Jun 2018. Investors include Lux Capital, DCVC (Data Collab) and Dolby Family Ventures.